Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dronedarone 400 MG Oral Tablet [Multaq]

Known as: Dronedarone 400 mg ORAL TABLET, FILM COATED [Multaq], Multaq 400 MG Oral Tablet 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of dronedarone (Multaq®, Sanofi-Aventis… Expand
Is this relevant?
2012
2012
Pensee et developpee afin de se positionner comme un antiarythmique possedant un bon profil de tolerance et d'utilisation aisee… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2012
Review
2012
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of dronedarone (Multaq®, Sanofi-Aventis… Expand
  • table I
  • table II
Is this relevant?
2011
2011
The prevalence of atrial fibrillation (AF) is increasing as well as the population is aging. Currently the therapeutic options… Expand
  • figure 1
  • table 2
Is this relevant?
2011
2011
Nous savons depuis l’étude CAST au moins que les anti­ arythmiques (AA) peuvent avoir de graves effets indési­ rables. Plusieurs… Expand
Is this relevant?
2011
2011
Spätestens seit der CAST-Studie wissen wir, dass Antiarrhythmika (AA) schwerwiegende Nebenwirkungen haben können. Nicht wenige AA… Expand
Is this relevant?